Lilly's Prices After Concessions Rise 6% In 2017, While Merck's Net Prices Decline

 
• By Cathy Kelly
  
group of businessman in black suit and holding red arrow down graph
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access